Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

0% Complete

Course Overview

NA

Course Content

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

Course Details

Duration: 0.00 hour
Released: May 14, 2025
Last Review: May 14, 2025
Expires: May 14, 2028

Objectives

NA

Target Audience

NA

Faculty & Disclosure

Faculty

Vicente Valero, MD

Disclosure

Vicente Valero, MD discloses no such relationships exist

Accreditation

NA

Related Courses

2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer

2026 Winter Cancer Symposium | Optimal Therapy for Metastatic Triple Negative Breast Cancer

0.00 AMA PRA Category 1 Credits™

2026 Winter Cancer Symposium | New therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs

2026 Winter Cancer Symposium | New therapies for Metastatic Hormone Receptor Positive Breast Cancer: Sequencing SERDs, CDKi, PI3Ki and ADCs

0.00 AMA PRA Category 1 Credits™

Explore More Courses